Blue Canaries (Publius) Profile picture
* Unapologetic American * 2 Cor 1:1-11 Dont let your comfort zone become your kill zone. https://t.co/LycgjHv8Me

Jun 26, 2020, 11 tweets

Drug for #COVID19 now: #REMDESIVIR : made by Gilead

Gilead holds the PATENT and that means that it has a monopoly on the drug in the US. It's the only company that can manufacture it until 2037, at which point a generic version could be possible.

2. Remdesivir: article from end of April "...looked at the chemical synthesis of the drug and concluded that a 10-day course for one person would cost $9, allowing for 20% losses during formulation, plus the cost of the vials, a profit margin, and tax."
arstechnica.com/science/2020/0…

3. NIH has also invested millions in potential treatments for COVID-19, like remdesivir, a drug made by Gilead Sciences that has been authorized by the Food and Drug Administration for emergency use for hospitalized patients with severe disease. middletownpress.com/news/coronavir…

4. On January 21, it was reported that China’s Wuhan Institute of Virology of the Chinese Academy of Sciences filed a patent for commercial use of remdesivir in China. 
trialsitenews.com/wuhan-institut…

5. ...Gilead will announce its pricing plans for remdesivir soon and start selling it commercially in the second half of the year... The analysts estimate the price will be $5,000 per course in the U.S., $4,000 in Europe and $2,000 elsewhere. fiercepharma.com/pharma/remdesi…

6. Remdesivir’s contribution pushed SVB Leerink’s estimate for Gilead’s total sales in 2021 up 28% to

$30 billion!!!!

7. Medical wisdom:
Hydroxychloroquine (HCQ)

VS.

Money:
Remdesivir, an intravenous (IV) experimental antiviral medicine
aapsonline.org/a-tale-of-two-…

@threadreaderapp please unroll. Thanq÷

IMPORTANT TO NOTE:

About 25 percent of patients receiving remdesivir had potentially severe side effects, including multiple organ dysfunction, septic shock, acute kidney injury, and low blood pressure. Another 23% showed evidence on lab tests of liver damage.

25%

Gilead history:
Chairman of Gilead Sciences Donald Rumsfeld & Board Member, Former U.S. Secretary of State, George Schultz profited heavily from a $1.5 billion stockpiling by the U.S. government on Tamiflu leading up to the 2009 H1N1 “swine flu” outbreak
greatgameindia.com/gilead-science…

@threadreaderapp please unroll

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling